Skip to main content
. Author manuscript; available in PMC: 2010 Sep 1.
Published in final edited form as: Hepatology. 2009 Sep;50(3):808–814. doi: 10.1002/hep.23082

TABLE 4.

Development of Primary Endpoints

Primary Endpoints UDCA Placebo
Death 5 3
Liver Transplant 11 5
Minimal Listing Criteria for Liver Transplant 13 10
Development of Cirrhosis 6 4
Esophageal and/or Gastric Varices 15 5
Cholangiocarcinoma 2 2

Total Endpoints 52 29

Number of Patients Reaching a Primary Endpoint 30 19
Number of Patients Reaching Death, OLT, Minimal Criteria Listing 22 15